Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Price$34.19

Value ScoreC

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)13.94%

Price vs S&P 500 (4W)-7.03%

VGM Score54.13

Market Capitalization$114.94B

P/E Ratio (Annual)27.59x

All Metrics

P/CF (Annual)23.61x

Book Value / Share (Quarterly)$7.07

P/TBV (Annual)9.47x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)4.96%

Cash Flow / Share (Quarterly)$1.01

Price vs S&P 500 (YTD)-8.21%

Gross Margin (TTM)52.77%

Net Profit Margin (TTM)9.03%

EPS (TTM)$1.34

10-Day Avg Trading Volume1.09M

EPS Excl Extra (TTM)$1.34

Revenue Growth (5Y)0.71%

EPS (Annual)$1.21

ROI (Annual)5.71%

Gross Margin (Annual)52.87%

Net Profit Margin (5Y Avg)-3.80%

Cash / Share (Quarterly)$3.21

P/E Basic Excl Extra (TTM)24.84x

Revenue Growth QoQ (YoY)2.34%

P/E Normalized (Annual)27.59x

ROA (Last FY)3.46%

Revenue Growth TTM (YoY)4.41%

EBITD / Share (TTM)$2.81

ROE (5Y Avg)-9.48%

Operating Margin (TTM)13.19%

Cash Flow / Share (Annual)$1.00

P/B Ratio4.73x

P/B Ratio (Quarterly)4.43x

Net Income / Employee (Annual)$45,300

EV / Revenue (TTM)2.99x

Net Interest Coverage (TTM)2.41x

ROA (TTM)3.90%

EPS Growth QoQ (YoY)67.39%

EV / EBITDA (TTM)15.77x

EPS Incl Extra (Annual)$1.21

Current Ratio (Annual)1.04x

Quick Ratio (Quarterly)0.70x

3-Month Avg Trading Volume1.43M

52-Week Price Return11.38%

EV / Free Cash Flow (Annual)45.14x

P/E Incl Extra (TTM)24.84x

Revenue / Employee (TTM)$556,500

Tangible BV / Share (Quarterly)$3.97

P/S Ratio (Annual)2.26x

Asset Turnover (Annual)0.42x

52-Week High$11350.00

Operating Margin (5Y Avg)1.90%

EPS Excl Extra (Annual)$1.21

CapEx CAGR (5Y)-2.82%

Tangible BV CAGR (5Y)30.21%

26-Week Price Return21.87%

Quick Ratio (Annual)0.72x

13-Week Price Return-5.99%

Total Debt / Equity (Annual)2.12x

Current Ratio (Quarterly)1.01x

Enterprise Value$51.82B

Revenue / Share Growth (5Y)-0.50%

Asset Turnover (TTM)0.43x

Book Value / Share Growth (5Y)-5.53%

Revenue / Employee (Annual)$553,600

Inventory Turnover (Annual)2.63x

Pretax Margin (Annual)7.09%

Cash / Share (Annual)$3.09

3-Month Return Std Dev38.49%

Gross Margin (5Y Avg)50.54%

Net Income / Employee (TTM)$50,300

EBITDA Interim CAGR (5Y)14.09%

ROE (Last FY)17.84%

Net Interest Coverage (Annual)2.51x

EPS Basic Excl Extra (Annual)$1.21

P/FCF (TTM)28.21x

Receivables Turnover (TTM)5.12x

EV / Free Cash Flow (TTM)44.21x

Total Debt / Equity (Quarterly)2.02x

EPS Incl Extra (TTM)$1.34

Receivables Turnover (Annual)5.10x

ROI (TTM)6.42%

P/S Ratio (TTM)2.24x

Pretax Margin (5Y Avg)-4.33%

Revenue / Share (Annual)$14.84

Tangible BV / Share (Annual)$3.59

Forward P/E13.54x

Free OCF CAGR (5Y)12.47%

Price vs S&P 500 (52W)17.87%

P/E Ratio (TTM)24.84x

Year-to-Date Return-1.24%

5-Day Price Return2.47%

EPS Normalized (Annual)$1.21

ROA (5Y Avg)-1.34%

Net Profit Margin (Annual)8.18%

Month-to-Date Return1.27%

Cash Flow / Share (TTM)$-3.69

EBITD / Share (Annual)$2.72

Operating Margin (Annual)12.50%

LT Debt / Equity (Annual)1.89x

P/CF (TTM)22.71x

ROI (5Y Avg)-2.12%

P/E Excl Extra (TTM)24.84x

LT Debt / Equity (Quarterly)1.70x

EPS Basic Excl Extra (TTM)$1.34

P/TBV (Quarterly)7.89x

P/B Ratio (Annual)4.95x

Inventory Turnover (TTM)2.55x

Pretax Margin (TTM)7.87%

Book Value / Share (Annual)$6.88

Price vs S&P 500 (13W)-14.25%

Beta0.41x

P/FCF (Annual)33.91x

Revenue / Share (TTM)$14.71

ROE (TTM)20.74%

52-Week Low$5305.00

vGradeC

gGradeC

mGradeB

vgmGradeC

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.14

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	B	$34.19
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Teva is the world's leading generic pharmaceutical manufacturer, with approximately half its revenue derived from North America where it captures a high single-digit percentage of US generic prescriptions. Beyond generics, the Israel-based company operates a specialty portfolio including innovative medicines and biosimilars across central nervous system, respiratory, and oncology therapeutic areas. Teva also generates revenue through active pharmaceutical ingredients, contract manufacturing, and Anda, its US-based generic and specialty drug distributor.